fibrosis
Startup Gero to Advance Epigenetic Biomarker Discovery Through Foxo Technologies Partnership
Premium
As Gero moves its operations from Russia and Singapore to the US, partner Foxo will provide longitudinal DNA methylation data to inform AI and validate recent research.
Veracyte Raises $55.1M in Public Offering
The company said proceeds will be used for working capital, and may also be used to acquire or invest in complementary businesses or technologies.
Veracyte Prices $51.3M Public Offering
Veracyte will offer 5 million shares at $10.25 per share. It has granted underwriters an option to purchase an additional 750,000 shares.
Despite an initial focus on cardiovascular disease, Miragen has moved programs in hematological cancer and fibrosis to the front of its pipeline.
Edinburgh Molecular Imaging Receives $6.5M Investment
NEW YORK (GenomeWeb News) – Molecular imaging firm Edinburgh Molecular Imaging has received £4 million ($6.5 million) in a Series A investment, life science capital venture fund Epidarex Capital announced today.
Aug 15, 2013
Jun 6, 2013
Nov 29, 2012
Jun 18, 2012
KineMed, GSK Partner on Biomarker Discovery Deal
Mar 13, 2012
Epistem, GSK Partner to Better Understand Fibrosis
Jun 24, 2010